Proteome Sciences plc (LON:PRM – Get Free Report) reached a new 52-week low on Friday . The stock traded as low as GBX 3.01 ($0.04) and last traded at GBX 2.50 ($0.03), with a volume of 15 shares. The stock had previously closed at GBX 3.01 ($0.04).
Proteome Sciences Trading Down 16.9 %
The firm’s 50-day simple moving average is GBX 3.28 and its two-hundred day simple moving average is GBX 3.52. The stock has a market capitalization of £7.38 million, a PE ratio of -301.00 and a beta of 0.07.
Proteome Sciences Company Profile
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Recommended Stories
- Five stocks we like better than Proteome Sciences
- How Investors Can Find the Best Cheap Dividend Stocks
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- What is a support level?
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- What Are Dividend Challengers?
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
